Evidence map›Paper›PMID 34822042›Full record

ArticleJournal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing2022

Left atrial appendage occlusion in haemophilia patients with atrial fibrillation.

Anders Dahl Kramer, Kasper Korsholm, Andreas Kristensen, Lone Hvitfeldt Poulsen, Jens Erik Nielsen-Kudsk

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. The aging hemophilia patient.Hematology. American Society of Hematology. Education Program · 2025
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anders Dahl KramerDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark. anha@clin.au.dk.ORCID http://orcid.org/0000-0002-5546-8693
Kasper KorsholmDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Andreas KristensenDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Lone Hvitfeldt PoulsenDepartment of Haematology, Haemophilia Centre West, Aarhus University Hospital, Aarhus, Denmark.
Jens Erik Nielsen-KudskDepartment of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Aarhus University Hospital · DKUniversity Hospital of North Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAdvanced targeted therapy has resulted in increasing life expectancy and incidence of age-related cardiovascular diseases like atrial fibrillation in patients with haemophilia. Oral anticoagulation constitutes a significant dilemma in this patient category as the risks of stroke and bleeding are difficult to balance. We sought to demonstrate the feasibility of left atrial appendage occlusion (LAAO) in patients with haemophilia and atrial fibrillation.

methodsAll patients with haemophilia treated with LAAO at Aarhus University Hospital, Denmark, were identified from a local prospective database comprising all consecutive LAAO procedures from 2010 up to November 2020. Based on review of the medical records, a retrospective descriptive analysis was performed.

resultsSeven patients with haemophilia A and atrial fibrillation underwent LAAO after multidisciplinary conference. Peri-procedural coagulation management was guided by factor VIII activity and treated with repeated bolus administrations of recombinant factor VIII targeting an activity of 100%. The implantation was successful in all patients with only minor bleeding complications post-procedurally. Based on these experiences, a suggested regime has been formulated.

conclusionsLAAO is feasible in haemophilia patients with concurrent atrial fibrillation. However, special care including intravenous substitution with coagulation factors must be given in the periprocedural management.

Indexed as

Atrial AppendageAtrial FibrillationHemophilia ASeptal Occluder DeviceStrokeFactor VIIIHumansRetrospective StudiesTreatment OutcomeFactor VIIIAtrial fibrillationFactor replacement therapyHaemophiliaLeft atrial appendage occlusion

Identifiers

PMID34822042
OpenAlexW3215683597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.